Oscar Health (NYSE:OSCR) Sees Strong Trading Volume - Here's Why

Oscar Health, Inc. (NYSE:OSCR - Get Free Report) saw an uptick in trading volume on Thursday . 5,599,746 shares were traded during trading, an increase of 24% from the previous session's volume of 4,500,903 shares.The stock last traded at $15.54 and had previously closed at $14.15.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on OSCR. Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their target price for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Wall Street Zen lowered shares of Oscar Health from a "buy" rating to a "hold" rating in a report on Sunday. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $18.50.

Oscar Health Stock Performance

The company has a market capitalization of $3.92 billion, a price-to-earnings ratio of -770.11 and a beta of 1.73. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26. The stock has a 50-day simple moving average of $13.87 and a 200-day simple moving average of $14.54.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. The firm had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The firm's revenue was up 42.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.62 EPS. On average, analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Insider Transactions at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the sale, the director now directly owns 64,512 shares of the company's stock, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 24.39% of the company's stock.

Institutional Trading of Oscar Health

Institutional investors have recently added to or reduced their stakes in the business. Hsbc Holdings PLC boosted its holdings in shares of Oscar Health by 2.7% in the 1st quarter. Hsbc Holdings PLC now owns 24,113 shares of the company's stock valued at $313,000 after buying an additional 632 shares during the period. Tempus Wealth Planning LLC lifted its holdings in Oscar Health by 6.7% in the first quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company's stock worth $189,000 after acquiring an additional 906 shares during the last quarter. Focus Partners Wealth lifted its holdings in Oscar Health by 1.8% in the first quarter. Focus Partners Wealth now owns 55,158 shares of the company's stock worth $723,000 after acquiring an additional 949 shares during the last quarter. Xponance Inc. boosted its stake in Oscar Health by 7.1% in the first quarter. Xponance Inc. now owns 15,423 shares of the company's stock valued at $202,000 after acquiring an additional 1,029 shares during the period. Finally, CWM LLC grew its holdings in shares of Oscar Health by 50.7% during the first quarter. CWM LLC now owns 3,204 shares of the company's stock valued at $42,000 after purchasing an additional 1,078 shares during the last quarter. Institutional investors own 75.70% of the company's stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.